Metabolic syndrome overview: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Metabolic syndrome]] occurs in the presence of [[insulin]] resistance and accompanying [[obesity]]. It increases the risk for [[coronary heart disease]], [[diabetes, fatty liver, stroke and some cancers. It may manifests as hypertension, hyperglycemia, hypertriglyceridemia, reduced high-density lipoprotein cholesterol and abdominal obesity. | |||
It affects a large number of people in a clustered fashion. In some studies, the [[prevalence]] in the USA is calculated as being up to 25% of the population. | |||
==See also== | ==See also== | ||
Revision as of 21:11, 27 September 2011
|
Metabolic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic syndrome overview On the Web |
|
American Roentgen Ray Society Images of Metabolic syndrome overview |
|
Risk calculators and risk factors for Metabolic syndrome overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Metabolic syndrome occurs in the presence of insulin resistance and accompanying obesity. It increases the risk for coronary heart disease, [[diabetes, fatty liver, stroke and some cancers. It may manifests as hypertension, hyperglycemia, hypertriglyceridemia, reduced high-density lipoprotein cholesterol and abdominal obesity. It affects a large number of people in a clustered fashion. In some studies, the prevalence in the USA is calculated as being up to 25% of the population.